Columbia's Progressive March
Columbia Universitys commencement demonstrates the far left ideology of its faculty, but suggests that for students, much of this is performative.
Last week, I attended my nephews graduation from Columbia College, Columbias Ivy League undergraduate division. As an alumnus of the college, as well as of Columbias business and law schools, I found the ceremony and left-leaning speeches familiar. As a conservative, even then, I was often verbally attacked by other students. On successive April Fools days, Columbia Daily Spectator even lampooned me as Kevin Spewak, spokesman for the fictional "Columbia Students in Opulence."
Despite Columbias long-time liberal bent, including what we now refer to as "wokeness," its students generally embraced core principles of American exceptionalism, worked hard, and pursued traditional careers. Ironically, given todays problems, one of my classmates, David Friedman, became U.S. ambassador to Israel, and another, Michael Oren, became Israels ambassador to the U.S.
When I attended the college, it admitted only men. Women were welcome at the engineering school, and Columbias affiliate, Barnard College. Last year, 51% of Columbias undergraduates were women (63%, including Barnard). Comparable to my class, about 15% of the graduating seniors were foreigners. Unlike my class, 63% of the Americans were minority students. That is a direct result of DEI.
At the graduation ceremony, nearly every award was presented to a student pursuing studies in a woke subject, such as sustainable development or African-American studies (neither of which existed when I was a student), and most were engaged in progressive activities, such as interning with Council on American-Islamic Relations (CAIR), a hate group that advances Hamas objectives in the United States, or campaigning for tenants rights.
The students gave a warm welcome to the colleges dean, Josef Sorett, a professor who focuses on African-American sexual politics and social justice, and who chaired Columbias Inclusive Public Safety Advisory Committee. Sorett was one of four Columbia deans who exchanged disparaging texts about Jews last year during a forum on antisemitism. He defended their prejudice by criticizing publication of their texts as an invasion of privacy. Only in a woke, antisemitic administration would Sorett have retained his job.
The universitys acting president, former ABC anchor Claire Shipman did not receive as warm a welcome. A meaningful percentage of the seniors, and some guests, heckled her and broke into chants demanding freedom for Mahmoud Khalil, the Columbia graduate student facing deportation for his role as an agent provocateur for Hamas. Shipman responded with humor and grace, and the heckling subsided after a few minutes.
Two days later, the Civil Rights Office of the Department of Health and Human Services found Columbia in violation of Title VI of the Civil Rights Act of 1964 by "acting with deliberate indifference towards student-on-student harassment of Jewish students from October 7, 2023, through the present."
Still, the substance and brevity of the protest shows both the misguided priorities of students and the performative shallowness of their concerns. Students ended the demonstration so they could receive their diplomas, giving short shrift to Khalil and those who objected to Shipmans bringing in the police to evict pro-Palestinian demonstrators from Butler Library.
That pragmatism is consistent with the majors selected by the vast majority of Columbias students. While the awards went to students adopting the progressive mantra, more than 96% of the majors and concentrations selected by seniors fell into traditional disciplines such as history, political science, computer science, math, and literature. Just 70 of 1,708 majors and concentrations were in sustainable development, human rights, ethnicity and race studies, or the like.
Relatively few students attended the separate graduation ceremonies for Asian, black, "Lavender" (LGBTQIA+), native, and other "affinity groups." There was little interest in what New York Times reporter Jodi Kantor (best known for her concerns about flags flown by the wives of Supreme Court justices) had to say. On the other hand, while just 4% of Hispanics support the use of "Latinx," that is how they are labeled at Columbia. It also seemed that every student lauded from the stage was a dual major who studied at the "intersection" of something of progressive significance. I had a dual major when I attended Columbia. I didnt realize that made me intersectional.
When a university promotes intersectional, oppressor dogma, approves of antisemitic tweets, and bestows praise only on the tiny minority of its students who exemplify progressive ideology, the result is a boot camp for DEI, open borders, social justice for criminals, antisemitism, and a liberal rules-based order.
But, a look under the keffiyeh shows that the indoctrination may not endure, and the substantial majority of students of all races and national origins may soon enough refocus on traditional careers and success. For true converts, if they shun violence, the beauty of America is the right of citizens to hold and advocate misguided views. I doubt Columbia credits American exceptionalism for that liberty.
Kenin M. Spivak is founder and chairman of SMI Group LLC, an international consulting firm and investment bank. He is the author of fiction and non-fiction books and a frequent speaker and contributor to media, including RealClearPolitics, The American Mind, National Review, television, radio, and podcasts.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


New York Post
38 minutes ago
- New York Post
Hamas' cease-fire ‘counteroffer' is just a demand for Israel to give up the war
Hamas on Saturday announced it had 'responded to' the latest ceasefire proposal from US envoy Steve Witkoff, apparently seeking assurances that Israel won't simply go back to eliminating it when the 60-day pause is up. Reality check: The terrorists are only talking because they're losing, badly — losing whatever support they had from ordinary Gazans as well as militarily. Hamas' main hope is to somehow manipulate Team Trump's peace efforts into a license to survive — to somehow have the war end with it intact in Gaza, still in power and with its sponsors and enablers again resupplying it. Advertisement To that end, it aims to leverage President Donald Trump's hopes to end the bloodshed as well as: Israeli public opinion, include the deep desire to recover the 20 or so still living hostages as well as the remains of the dozens who've died in captivity, plus general war-weariness and partisan opposition to Prime Minister Benjamin Netanyahu and his coalition Sympathy for its other hostages: Gaza's 2 million civilians. Hamas has never cared a whit for their lives or well-being, except as potential recruits, human shields and reason for an influx of aid that the terrorists can siphon off for their use. It will happily martyr any or all of them for the cause of destroying Israel — even as it pretends to make concessions in their name to serve its true agenda. Advertisement Its de facto fifth column all across the West, including the 'tentifada' fanatics and fools on Columbia and other campuses, and all the politicians and media figures who buy the terrorists' propaganda. The dogged self-deception of the international 'peace process' veterans, still imagining that a 'two-state solution' is the key to resolving all the region's conflicts — an 'answer' that's now a complete fantasy that disregards every development of the last three decades. Arab rulers' inability to simply abandon decades of anti-Israel propaganda even though they (mostly) recognize it no longer serves their most urgent needs. Israel's current offensive has already taken out hundreds more Hamas fighters and yet another round of leadership, including the last Sinwar. The IDF is poised to take full control of Gaza, clear the final bunkers and tunnels and crush the remaining terror brigades. Advertisement And Jerusalem has cut off Hamas' resupply, refusing to allow aid to enter Gaza without firm controls that ensure it goes straight to civilians. Not allowing the terrorists to capture it — and to charge civilians for access to any of it — has helped turn the tide of public opinion: Ordinary Gazans increasingly know the war continues only because Hamas won't surrender or even negotiate a departure of its remaining forces. Witkoff's latest offer would have Hamas turn over 10 living hostages and a dozen or two bodies, in exchange for 125 terrorists serving life sentences plus another 1,000-plus jailbirds and a 60-day ceasefire and ongoing talks toward a full peace settlement. But Hamas knows full well that Netanyahu won't end the war until the terrorists are all dead, surrendered or expelled from Gaza: He refuses to allow for any possibility of another Oct. 7, and Israeli public opinion so far supports him. Advertisement So the terror group's counteroffer is to demand some kind of guarantee that Washington won't let the IDF resume operations when the 60 days are up, as well as the resumption of aid entering under UN or similar auspices, without Israeli controls. As things stand, Hamas is toast within months. To get hostages returned, Israel will allow it a respite — and so risk some development (Netanyahu's ouster, a drastic shift in the region, Washington concluding it needs the war ended; who knows?) that would let the terror group hang on in Gaza. Unless Team Trump decides to overrule Israel's unchanged war goals, Hamas will have to settle for that hope of a lifeline, or no deal is happening.


The Hill
an hour ago
- The Hill
Puerto Rico is Trump's perfect partner in reshoring
President Trump recently signed an executive order to bring pharmaceutical manufacturing back to the U.S. by streamlining the process for the Food and Drug Administration to approve pharmaceutical manufacturing plants. This is the latest in the Trump administration's agenda to protect national security and create American jobs by promoting the reshoring of critical supply chains that Americans rely on every day. These efforts are coupled with international tariffs to encourage domestic manufacturing. Reshoring pharmaceutical manufacturing is not only dire for American national security, but it could have resounding economic impacts across the country. One U.S. jurisdiction that is ready and in a perfect position to partner in this effort is Puerto Rico, where pharmaceutical manufacturing is already a more than $50 billion industry. With complementary efforts underway in Congress and on the island, the White House should look to Puerto Rico as America's pharmaceutical powerhouse while not trapping the island in its current territory status by hindering a future transition to statehood that would further boost the island's manufacturing ability. As a territory, the island is part of the U.S. customs zone and is not subject to U.S. tariffs, and everything that is made in Puerto Rico is 'Made in the USA.' Yet, that same territory status has limited Puerto Rico's economic development by creating persistent uncertainty, underinvestment and an unequal playing field for economic competition. The territory status is unpopular on the island, and Puerto Rican voters have voted in favor of statehood four consecutive times, most recently last November. Trump and Congress have the opportunity of a generation to leverage the pharmaceutical infrastructure and workforce in Puerto Rico to achieve their agenda while also turbocharging the economy on the island, and they have the perfect ally in Puerto Rico to do it with — the island's Republican Gov. Jenniffer González-Colón. González-Colón is leading an ambitious agenda to reshape the national narrative about the island and its people — and ultimately achieve statehood for Puerto Rico. Aligning with the Trump administration's vision to reshore advanced manufacturing of critical products, she issued an executive order in late March and reached out to top White House officials to offer Puerto Rico's well-established, yet currently underutilized, manufacturing capacity as an economic engine to help grow American prosperity. González-Colón's executive order promotes the relocation of overseas manufacturing of pharmaceuticals and other products to Puerto Rico. Much like Trump's executive order, it eliminates barriers and streamlines the process for businesses to move to the island. This action is complementary to the Medical Manufacturing, Economic Development and Sustainability Act, which was recently reintroduced and incentivizes pharmaceutical manufacturing on the island and throughout economically distressed zones across the United States. The bill is designed to attract business to the island in a way that invests in the people of Puerto Rico. It does this by providing an incentive for medical manufacturing facilities to relocate to economically distressed zones, with an incentive dependent on the number of jobs created to ensure money is flowing back into communities. The incentive itself is based on economic factors and applies to communities throughout the United States — an appropriately wide scope that comports with Trump's strong desire to reshore large amounts of production in a short time frame. By tethering the tax credits to what manufacturers invest directly into wages, salaries and real middle-class benefits, the proposal creates good-paying, quality American jobs. Reshoring to Puerto Rico would mean that critical pharmaceuticals and medical devices, as well as other products that are currently manufactured overseas in China and other nations, would now be produced in America. This would create thousands of well-paying manufacturing jobs that Puerto Rico needs to turbocharge the modest economic progress it's made in recent years. The increased consumer demand on the island would help boost the approximately $70 billion in annual interstate commerce, resulting in more jobs and profits stateside. Puerto Rico is a natural partner in reshoring the medical and pharmaceutical manufacturing industry within U.S. borders. The island's leaders share in the White House's vision of a more prosperous pharmaceutical manufacturing industry and are working to ensure reshoring efforts do not trap Puerto Rico in its current territory status but instead enable it to reach its full potential as an engine of economic growth and prosperity as a future state of our Union. Manufacturing makes America stronger, especially when it lifts up communities and the hard-working American citizens that make 'Made in the USA' a possibility, including those in Puerto Rico.


New York Times
an hour ago
- New York Times
Muhammad Sinwar, a Top Military Leader of Hamas, Is Dead, Israel Says
The Israeli military announced on Saturday night that it had killed Muhammad Sinwar, one of Hamas's top military commanders in Gaza, during airstrikes this month that targeted the vicinity of a hospital in southern Gaza. Hamas did not immediately respond to the claim of Mr. Sinwar's death. During the war in Gaza, the Palestinian armed group has largely not confirmed the killing of its commanders in the moment, only announcing their demise weeks or even months later, if at all. Mr. Sinwar's death would be a blow to Hamas. The brother of Yahya Sinwar, the former Hamas leader killed by Israel last year, he was one of the most powerful Hamas leaders in Gaza still alive after nearly 20 months of war with Israel. But Mr. Sinwar's death may not immediately change Hamas's strategy or operations, analysts said. Since the war began more than a year and a half ago, Israel has targeted and killed a number of Hamas's top leaders, only to see the group continue its insurgency war against Israel in Gaza. This month, Israeli aircraft struck an underground compound near the European Hospital, close to the southern Gaza city of Khan Younis, where Mr. Sinwar had recently been present, according to the Israeli military. At the time, Israeli officials said privately that they had been targeting Mr. Sinwar, but they did not mention him in their announcement of the strikes. Want all of The Times? Subscribe.